Anna R. Giampetruzzi
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Emotional regulation and personality in systemic sclerosis: evaluating autogenic training in real-world setting.
Journal: Italian journal of dermatology and venereology
Published: May 21, 2026
Linagliptin is a risk factor for bullous pemphigoid associated with BP180-NC16A/BP230 seronegativity and milder severity: Evidence from a prospective case-control study supporting ECD-BP180 enzyme-linked immunosorbent assay in reducing diagnostic delay.
Journal: Journal of the American Academy of Dermatology
Published: February 16, 2026
Distinctive Reactivity to the C-terminal Epitope of BP180 Characterizes Immune Checkpoint Inhibitor-associated Bullous Pemphigoid, and an ELISA Based on the BP180 Ectodomain Enables Prompt Diagnosis in a Subset of Patients.
Journal: Acta dermato-venereologica
Published: January 09, 2026
Distinctive Reactivity to the C-terminal Epitope of BP180 Characterizes Immune Checkpoint Inhibitor-associated Bullous Pemphigoid, and an ELISA Based on the BP180 Ectodomain Enables Prompt Diagnosis in a Subset of Patients.
Journal: Acta dermato-venereologica
Published: January 09, 2026
Bullous pemphigoid associated with canagliflozin intake.
Journal: Italian journal of dermatology and venereology
Published: October 03, 2025
Efficacy of JAK inhibitors in treating dominant dystrophic epidermolysis bullosa and alopecia areata.
Journal: Italian journal of dermatology and venereology
Published: October 03, 2025
Living with systemic sclerosis: Prevalence of itch and other skin symptoms and their association with psychosocial issues.
Journal: Journal of health psychology
Published: July 30, 2025
Erythrodermic atopic dermatitis successfully treated with upadacitinib.
Journal: Italian journal of dermatology and venereology
Published: July 02, 2025
Emotional Dysregulation, Hopelessness and Dysmorphophobic Concerns Among Hospitalized Patients with Autoimmune, Inflammatory, and Metabolic Skin Disorders.
Journal: Behavioral sciences (Basel, Switzerland)
Published: January 30, 2025
Biological therapies in infants and children younger than 6 years of age with atopic dermatitis: suitability and practical considerations.
Journal: Expert opinion on drug safety
Published: December 21, 2024
Bullous pemphigoid and mucous membrane pemphigoid humoral responses differ in reactivity towards BP180 midportion and BP230.
Journal: Frontiers in immunology
Published: September 10, 2024
Potential role of mindfulness in the adjuvant treatment of atopic dermatitis.
Journal: Skin health and disease
Published: May 16, 2024
Last Updated: 09/26/2026